IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-48616-3.html
   My bibliography  Save this article

Drug screening on digital microfluidics for cancer precision medicine

Author

Listed:
  • Jiao Zhai

    (University of Macau
    City University of Hong Kong)

  • Yingying Liu

    (University of Macau
    University of Macau)

  • Weiqing Ji

    (University of Science and Technology Beijing)

  • Xinru Huang

    (Sun Yat-Sen University)

  • Ping Wang

    (The First Affiliated Hospital of Guangzhou Medical University)

  • Yunyi Li

    (University of Macau)

  • Haoran Li

    (University of Macau
    University of Macau)

  • Ada Hang-Heng Wong

    (University of Macau)

  • Xiong Zhou

    (University of Macau
    Hunan University)

  • Ping Chen

    (University of Macau)

  • Lianhong Wang

    (Hunan University)

  • Ning Yang

    (University of Macau
    Jiangsu University)

  • Chi Chen

    (Sun Yat-Sen University)

  • Haitian Chen

    (Sun Yat-Sen University)

  • Pui-In Mak

    (University of Macau
    University of Macau)

  • Chu-Xia Deng

    (University of Macau)

  • Rui Martins

    (University of Macau
    University of Macau
    Universidade de Lisboa)

  • Mengsu Yang

    (City University of Hong Kong)

  • Tsung-Yi Ho

    (The Chinese University of Hong Kong)

  • Shuhong Yi

    (Sun Yat-Sen University)

  • Hailong Yao

    (University of Science and Technology Beijing)

  • Yanwei Jia

    (University of Macau
    University of Macau
    University of Macau)

Abstract

Drug screening based on in-vitro primary tumor cell culture has demonstrated potential in personalized cancer diagnosis. However, the limited number of tumor cells, especially from patients with early stage cancer, has hindered the widespread application of this technique. Hence, we developed a digital microfluidic system for drug screening using primary tumor cells and established a working protocol for precision medicine. Smart control logic was developed to increase the throughput of the system and decrease its footprint to parallelly screen three drugs on a 4 × 4 cm2 chip in a device measuring 23 × 16 × 3.5 cm3. We validated this method in an MDA-MB-231 breast cancer xenograft mouse model and liver cancer specimens from patients, demonstrating tumor suppression in mice/patients treated with drugs that were screened to be effective on individual primary tumor cells. Mice treated with drugs screened on-chip as ineffective exhibited similar results to those in the control groups. The effective drug identified through on-chip screening demonstrated consistency with the absence of mutations in their related genes determined via exome sequencing of individual tumors, further validating this protocol. Therefore, this technique and system may promote advances in precision medicine for cancer treatment and, eventually, for any disease.

Suggested Citation

  • Jiao Zhai & Yingying Liu & Weiqing Ji & Xinru Huang & Ping Wang & Yunyi Li & Haoran Li & Ada Hang-Heng Wong & Xiong Zhou & Ping Chen & Lianhong Wang & Ning Yang & Chi Chen & Haitian Chen & Pui-In Mak , 2024. "Drug screening on digital microfluidics for cancer precision medicine," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48616-3
    DOI: 10.1038/s41467-024-48616-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-48616-3
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-48616-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Mary V. Relling & William E. Evans, 2015. "Pharmacogenomics in the clinic," Nature, Nature, vol. 526(7573), pages 343-350, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ya-Yen Yu & Shih-Ming Tsao & Wen-Ta Yang & Wei-Chang Huang & Ching-Hsiung Lin & Wei-Wen Chen & Shun-Fa Yang & Hui-Ling Chiou & Yi-Wen Huang, 2019. "Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis," IJERPH, MDPI, vol. 17(1), pages 1-9, December.
    2. M Dahmani Fathallah, 2017. "Genomics, Gene Editing and Biologics: The Bolsters of the New Medical Paradigm," Current Trends in Biomedical Engineering & Biosciences, Juniper Publishers Inc., vol. 6(4), pages 75-78, July.
    3. Perry, Seth W & Allison, Stephen & Bastiampillai, Tarun & Wong, Ma-Li & Licinio, Julio & Sharfstein, Steven S. & Wilcox, Holly C., 2019. "Rising US Suicides: Achieving Health Equity," OSF Preprints m5q64, Center for Open Science.
    4. Degtiar, Irina, 2017. "A review of international coverage and pricing strategies for personalized medicine and orphan drugs," Health Policy, Elsevier, vol. 121(12), pages 1240-1248.
    5. Ligia Traldi Macedo & Vinicius Eduardo Ferrari & Juliana Carron & Ericka Francislaine Dias Costa & Leisa Lopes-Aguiar & Gustavo Jacob Lourenço & Carmen Silvia Passos Lima, 2019. "Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48616-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.